NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13243122

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Adjuvant for mucosal vaccines which modulates the effects of substances, including vaccine antigens in contact with mucosal body surfaces.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOTEC PHARMACON ASA9008 TROMSÖ

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BAKKE, Hilde Sunove Waleur Oslo, NO 2 50
BERSTAD, Aud Katherine Herland Oslo, NO 2 50
HANEBERG, Bjorn Oslo, NO 4 66
HAUGEN, Inger LISE Oslo, NO 3 55
HOLST, Johan Oslo, NO 5 69
JANAKOVA, Liba Oslo, NO 3 55
KORSVOLD, Gro Ellen Oslo, NO 3 55
OFTUNG, Fredrik Oslo, NO 3 55
RAA, Jan Oslo, NO 16 113

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation